fashion -WSS

fashion

author：comprehensive 2025-09-27 21:55:41 - browse：7

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： STAT Summit: Meghan O’Rourke on making chronic illness visible

WSS

House GOP plan to stem drug shortages differs from Democrats’

Poland's lawmakers approve a divisive law on Russian influence

How AI can help patients find reliable information about doctors

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

STAT Summit: Ending the crisis of Black deaths in the U.S.

Doctors in states that ban abortion can still help patients

hotspot

fashion

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Medical leaders decry Supreme Court decision on affirmative action

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CZI to create biohub to build anti

Activists slam private health insurers over coverage restrictions

Results on Novartis prostate cancer therapy could expand its use

focus

Teacher posts viral 'school supply rant' with advice for parents

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Study on Amgen’s bispecific immunotherapy produces positive data

HCA says smaller share of spending going to labor

What AstraZeneca

FDA clears Verve to begin U.S. study of gene

leisure time

hotspot

Wikipedia

hotspot